Financials

  • Market Capitalization 20.41 M
  • Employee 5
  • Founded 1979
  • CEO N/A
  • Website www.dyadic.com
  • Headquarter Delaware, United States
  • FIGI BBG000L276R1
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.27
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4525
MRKR
Marker Therapeutics, Inc. - Common Stock
1.33 USD-2.92%-11.33%+14.66%+47.78%22.18 M USD
4527
LGVN
Longeveron Inc. - Class A Common stock
6.90 USD+2.68%+845.21%+871.83%+1107.77%22.00 M USD
4554
NEUP
Neuphoria Therapeutics Inc. - Common Stock
3.76 USD0.00%-3.84%-2.59%-66.81%20.32 M USD
4555
AKTX
Akari Therapeutics Plc - American Depositary Shares
10.43 USD-2.52%+30.87%+38.88%+1254.55%20.31 M USD

Notizie